FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q1 2019

Top Holdings95 positions

Checking export access…
Activity:
AABAAABADelisted
Fund

ALTABA INC

27.6M$2B15.4%——
2 qtrssince 2018-Q4
Unchanged
0
SPYSPY
PUT

STATE STR SPDR S&P 500 ETF T

3.1M$880.6M6.6%———
Increased
—
CELGCELGDelisted

CELGENE CORP

8.4M$795.3M6.0%——
1 qtr
New
98
RHTRHTDelisted

RED HAT INC

3.3M$608.3M4.6%——
2 qtrssince 2018-Q4
Increased
70

WABTEC

6.2M$460.2M3.5%$67.51+4.50%
2 qtrssince 2018-Q4
Increased
65

ALPHABET INC

292,328$343M2.6%$51.29+13.30%
2 qtrssince 2018-Q4
Decreased
0
6.1M$332.1M2.5%——
2 qtrssince 2018-Q4
Increased
55
SPYSPY
CALL

STATE STR SPDR S&P 500 ETF T

1.1M$324M2.4%———
Decreased
—

BOOKING HOLDINGS INC

184,982$322.8M2.4%$67.39+1.17%
2 qtrssince 2018-Q4
Increased
59

IQVIA HLDGS INC

2.2M$310.4M2.3%$116.17+23.83%
2 qtrssince 2018-Q4
Decreased
0

META PLATFORMS INC

1.8M$304.9M2.3%$129.85+27.16%
2 qtrssince 2018-Q4
Decreased
0

TRANSUNION

4.3M$288.6M2.2%$54.71+17.81%
2 qtrssince 2018-Q4
Decreased
0

CHARTER COMMUNICATIONS INC

806,938$279.9M2.1%$284.97+21.74%
2 qtrssince 2018-Q4
Decreased
0

VISA INC

1.6M$251.6M1.9%$124.91+18.59%
2 qtrssince 2018-Q4
Decreased
0

FIDELITY NATL INFORMATION SV

2.1M$240.3M1.8%$88.05+9.41%
2 qtrssince 2018-Q4
Increased
54

ELEVANCE HEALTH INC FORMERLY

825,000$236.8M1.8%$235.91+9.56%
2 qtrssince 2018-Q4
Decreased
0
PLYAPLYADelisted

PLAYA HOTELS & RESORTS NV

30.6M$233.5M1.8%——
2 qtrssince 2018-Q4
Unchanged
0

EQUIFAX INC

2M$232.1M1.7%$87.10+27.70%
2 qtrssince 2018-Q4
Decreased
0

CITRIX SYSTEMS INC

2M$198.3M1.5%——
2 qtrssince 2018-Q4
Increased
62

MICROSOFT CORP

1.6M$192.3M1.4%$94.43+16.61%
2 qtrssince 2018-Q4
Decreased
0
$13.3B
AUM
95
Positions
Q1 2019
Filing
HI score · 1.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q1'19
New24%Increased18%Decreased33%Exited24%
Composition
Equity vs derivatives
Equity91%Puts7%Calls2%
Holding period
Avg <1 quarter
<1Q21%1-4Q79%1-2Y0%2Y+0%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $13.3B across 95 positions as of Q1 2019. Top holdings: AABA (15.4%), SPY puts (6.6%), CELG (6.0%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1.5/5.0.

Q1 2019 Summary

Active quarter - 20 new positions, 21 exits, 29 increased. Top move: CELG (NEW, conviction 98). Portfolio: $13.3B across 95 positions.

Top holdings by portfolio weight

Total AUM$12B
AABA15.39%
CELG5.98%
RHT4.58%
WAB3.46%
GOOG2.58%
IHS MARKIT L2.50%
BKNG2.43%
IQV2.33%
META2.29%
TRU2.17%
Other2.11%

Portfolio allocation by GICS sector

Sectors9
Unknown49.51%
Healthcare15.85%
Communication Services9.19%
Industrials7.29%
Financial Services6.18%
Consumer Cyclical4.68%
Technology4.07%
Real Estate1.85%
Basic Materials1.38%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L51
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC COM
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNX<![CDATA[CRINETICS PHARMACEUTICALS INC]]>
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used